Fundraising FoxEmerald Development Managers — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
LifeSprout develops synthetic materials that mimic the body's own tissues for aesthetic and regenerative medicine, creating products to treat patients with soft tissue loss from aging, cancer, and metabolic disease.
BiotechMedical DevicesNew MaterialsBaltimore, US
Hai-Quan Mao(Co-founder, PhD)Sashank Reddy(Co-founder, MD, PhD)Kevin Colbert(Co-founder, Business Development)inRuss Martin(Co-founder, Head of R&D, PhD)inAdam Gridley(Executive Chairman, MBA)
Co-investorsCatalio Capital Management, LPMaryland TEDCOTEDCO
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.